Chapter 26-Urinary System – Urine Production 02

Overview of Urine Production

• Three fundamental processes (occur continuously & simultaneously)
  • Filtration
    • Passive, non-specific movement of plasma‐like fluid from blood → Bowman’s (glomerular) capsule
    • Driven exclusively by hydrostatic pressure inside glomerular capillaries
    • ~$19\%$ of renal plasma is filtered on each pass
  • Tubular Reabsorption
    • Selective reclamation of $\approx 99\%$ of water & “wanted” solutes back into the blood (peritubular capillaries / vasa recta)
    • Takes place along PCT, Loop of Henle (LoH), DCT, Collecting Duct (CD)
  • Tubular Secretion
    • Active transport of additional, usually undesirable substances from blood → nephron lumen (mainly PCT & DCT)

Filtration in Detail

• Glomerular Filtration Barrier
  • Endothelium (fenestrated)
  • Basement membrane (negatively charged)
  • Filtration slits of podocytes
  → Permits passage of H₂O, ions, glucose, amino acids, small peptides, urea; retains cells, large proteins, strongly anionic macromolecules
• Driving Forces (Fig. 26.9)
  • Outward (favoring filtration)
    • Glomerular capillary blood pressure $P_{GC}=50\ \text{mm Hg}$
  • Inward (opposing filtration)
    • Capsular hydrostatic pressure $P<em>{CS}=10\ \text{mm Hg}$ • Blood colloid osmotic pressure $\pi</em>{GC}=30\ \text{mm Hg}$ (due to plasma proteins)
  • Net Filtration Pressure
    $P<em>{NF}=P</em>{GC}-(\pi<em>{GC}+P</em>{CS})$
    $\Rightarrow 50-(30+10)=10\ \text{mm Hg}$ (directs fluid → nephron)
• “Non-specific” nature means everything small gets through; selectivity occurs later by reabsorption & secretion

Renal & Plasma Flow Relationships

• Renal Blood Flow (RBF)
  $\text{RBF}=\text{Cardiac Output}\times\text{Renal Fraction}$
  $=5600\ \text{mL min}^{-1}\times0.21 \approx 1176\ \text{mL min}^{-1}$
• Renal Plasma Flow (RPF)
  $\text{RPF}=\text{RBF}\times \text{Plasma Fraction}$
  $=1176\ \text{mL min}^{-1}\times0.55 \approx 650\ \text{mL min}^{-1}$
• Glomerular Filtration Rate (GFR)
  $\text{GFR}=\text{RPF}\times\text{Filtration Fraction}$
  $=650\ \text{mL min}^{-1}\times0.19 \approx 125\ \text{mL min}^{-1}$ (≈180 L day⁻¹)
• Urine Flow Rate
  $\text{Urine Rate}=\text{GFR}\times\text{Fraction Not Reabsorbed}$
  $=125\ \text{mL min}^{-1}\times0.008 \approx 1\ \text{mL min}^{-1}$
  → $1\ \text{mL min}^{-1}\times1440\ \text{min day}^{-1}\approx1.4\ \text{L day}^{-1}$
• Physiological modifiers
  • Shock / intense exercise → sympathetic‐mediated afferent vasoconstriction ↓GFR ↓urine
  • Hydration state, hormones, drugs also adjust GFR

Autoregulatory Mechanisms (Keep GFR ~ constant 80–180 mm Hg MAP)

• Myogenic Response
  • Stretch of smooth muscle in afferent arteriole
  – ↑BP → afferent constriction → ↓PGC → ↓GFR – ↓BP → afferent dilation → ↑PGC → ↑GFR
  – Protective against hypertension & hypovolemic shock
• Tubuloglomerular Feedback
  • Macula densa (distal nephron) senses ↑NaCl (proxy for ↑GFR)
  • Secretes paracrine signals & stimulates renin release (JGA)
  • Angiotensin II causes preferential efferent > afferent constriction → overall ↓glomerular pressure → restores GFR

Plasma Clearance (Clinical Application)

• General formula
  $C<em>x = \frac{U</em>x\,\dot V}{P<em>x}$ where $U</em>x$ = urine concentration of solute $x$, $\dot V$ = urine flow (mL min⁻¹), $P_x$ = plasma concentration
• A perfect GFR marker (e.g., inulin, creatinine) must:
  • Be freely filtered
  • Not reabsorbed
  • Not secreted
  • Not synthesized/metabolized by kidney
• ↓GFR (renal failure) → ↓Clearance → $P<em>x\uparrow$ relative to $U</em>x$ (diagnostic)

Tubular Reabsorption Summary (≈99 % of filtrate rescued)

Proximal Convoluted Tubule (PCT) – "Bulk Reabsorber"

• Ions: $\text{Na}^+,\ \text{K}^+,\ \text{Cl}^-,\ \text{HCO}<em>3^-,\ \text{Ca}^{2+},\ \text{Mg}^{2+},\ \text{PO}</em>4^{3-}$
• Organics: glucose, fructose, galactose, amino acids, lactate, water (obligatory)
• Mechanisms: Na⁺/K⁺-ATPase energizes secondary active cotransport; aquaporin-1 channels for H₂O

Loop of Henle

• Thin Descending Limb
  • Highly permeable to H₂O (aquaporins), almost no solute transport
  • Water exits → filtrate osmolarity ↑
• Thin Ascending Limb
  • Impermeable to H₂O
  • Passive Na⁺ & Cl⁻ reabsorption (down gradient)
• Thick Ascending Limb ("Diluting Segment")
  • Absolutely impermeable to H₂O
  • Active NKCC symporter (Na⁺-K⁺-2 Cl⁻), plus Mg²⁺ & Ca²⁺ paracellular reabsorption
  • Generates corticomedullary osmotic gradient (counter-current multiplier)

Distal Convoluted Tubule (DCT)

• Reabsorbs Na⁺, Cl⁻ (Na⁺/Cl⁻ symporter), variable Ca²⁺ (PTH regulated)
• Early DCT continues dilution; late DCT under hormonal control (aldosterone, PTH)

Collecting Duct (CD)

• Principal cells: Na⁺ reabsorption (ENaC) & K⁺ secretion (aldosterone)
• Intercalated cells: H⁺ secretion / HCO₃⁻ reabsorption (acid-base)
• Water permeability regulated by ADH via aquaporin-2 insertion

Tubular Secretion – Getting Rid of the “Bad Stuff”

Proximal Tubule

• H⁺ (important for acid-base balance)
• Nitrogenous & hepatic wastes: ammonia, uric acid, bile salts
• Biogenic amines/neurotransmitters: acetylcholine, dopamine, epinephrine
• Many drugs: antibiotics, antivirals, NSAIDs, diuretics
• Toxins: heavy metals, organic solvents

Distal Convoluted Tubule / Collecting Duct

• H⁺ (fine-tuning pH)
• K⁺ (aldosterone-sensitive)

Tubular Load & Transport Maximum (T\textsubscript{m})

• Tubular Load: quantity of a substance delivered to a segment per minute (filtered + secreted)
• Transport Maximum (T\textsubscript{m}): highest rate at which carriers/enzymes can reabsorb or secrete
• When $\text{Load}>T_m$ → carriers saturated → excess appears in urine
  • Classic example: hyperglycemia → glycosuria
  • Raises tubular fluid osmolality → pulls water osmotically → polyuria (diuresis)

Composition of Normal Urine

• Highest concentration → lowest
  1. Organic wastes
     • Creatinine (from creatine phosphate in muscle)
     • Urea (protein catabolism)
     • Uric acid (nucleic acid metabolism)
  2. Electrolytes / Ions
     • $\text{K}^+>\text{Cl}^->\text{Na}^+>\text{HCO}_3^-$ (overall ionic strength ~300 mOsm)
• Absent in healthy urine
  • Proteins (\textless150 mg day⁻¹ ≈ trace)
  • Glucose (should be 0 mg dL⁻¹)

Clinical & Physiological Significance

• GFR is a critical indicator of renal health; used to stage chronic kidney disease (CKD)
• Autoregulation shields nephron from everyday BP fluctuations; failure → hypertensive nephropathy/kidney ischemia
• Counter-current mechanisms (LoH + vasa recta) enable urine concentration up to ~1200 mOsm → conserve water in dehydration
• Drug dosing often adjusted to plasma clearance; renal impairment requires lower or less frequent doses (e.g., aminoglycosides)
• Presence of protein or glucose in urine prompts evaluation for glomerular damage or diabetes mellitus, respectively

Key Equations (Quick Reference)

1. $P<em>{NF}=P</em>{GC}-\left(\pi<em>{GC}+P</em>{CS}\right)$
2. $\text{RBF}=\text{CO}\times\text{Renal Fraction}$
3. $\text{RPF}=\text{RBF}\times \text{Plasma Fraction}$
4. $\text{GFR}=\text{RPF}\times\text{Filtration Fraction}$
5. $\text{Urine Flow}=\text{GFR}\times(1-\text{Reabsorption Fraction})$
6. Clearance: $C<em>x=\dfrac{U</em>x\,\dot V}{P_x}$

Concept Connections / Broader Context

• Links to cardiovascular learning: renal fraction (~21 %) highlights kidney’s disproportionate perfusion for filtration vs. tissue mass
• Acid–base physiology: renal H⁺ secretion works with respiratory CO₂ removal to maintain $pH=7.35–7.45$
• Endocrine integration: renin–angiotensin–aldosterone system (RAAS) couples renal perfusion status to systemic blood pressure & Na⁺ balance
• Pathophysiology examples:
  • Diabetic nephropathy → loss of protein barrier → proteinuria
  • Loop diuretics inhibit NKCC in thick ascending limb → potent natriuresis & diuresis
  • Rhabdomyolysis releases myoglobin → filtered but can precipitate, causing acute tubular necrosis

Ethical / Practical Implications

• Proper disposal & environmental management of nephrotoxic drugs/solvents limits renal injury risks
• Early detection of CKD via GFR estimation allows intervention before end-stage renal disease (dialysis/transplant)
• Awareness of drug–drug interactions at renal secretion transporters (e.g., probenecid + penicillin) optimizes therapeutic efficacy and minimizes toxicity